Angion Biomedica (NASDAQ: ANGN)
$9.50
(1.0%)
$0.09
Price as of May 13, 2024, 3:29 p.m. ET
Angion Biomedica Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Angion Biomedica Company Info
Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.